- Home
- HYFM vs PRPH Comparison
HYFM vs PRPH Comparison
Compare HYFM & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFM
- PRPH
- Stock Information
- Founded
- HYFM 1977
- PRPH 1989
- Country
- HYFM United States
- PRPH United States
- Employees
- HYFM N/A
- PRPH N/A
- Industry
- HYFM Industrial Machinery/Components
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- HYFM Industrials
- PRPH Health Care
- Exchange
- HYFM Nasdaq
- PRPH Nasdaq
- Market Cap
- HYFM 17.3M
- PRPH 15.2M
- IPO Year
- HYFM 2020
- PRPH 1997
- Fundamental
- Price
- HYFM $3.97
- PRPH $0.43
- Analyst Decision
- HYFM Hold
- PRPH
- Analyst Count
- HYFM 2
- PRPH 0
- Target Price
- HYFM $7.00
- PRPH N/A
- AVG Volume (30 Days)
- HYFM 6.9K
- PRPH 4.1M
- Earning Date
- HYFM 08-07-2025
- PRPH 08-13-2025
- Dividend Yield
- HYFM N/A
- PRPH N/A
- EPS Growth
- HYFM N/A
- PRPH N/A
- EPS
- HYFM N/A
- PRPH N/A
- Revenue
- HYFM $176,650,000.00
- PRPH $5,845,000.00
- Revenue This Year
- HYFM $5.45
- PRPH $221.82
- Revenue Next Year
- HYFM $5.33
- PRPH N/A
- P/E Ratio
- HYFM N/A
- PRPH N/A
- Revenue Growth
- HYFM N/A
- PRPH N/A
- 52 Week Low
- HYFM $1.50
- PRPH $0.22
- 52 Week High
- HYFM $8.55
- PRPH $3.64
- Technical
- Relative Strength Index (RSI)
- HYFM 58.98
- PRPH 62.32
- Support Level
- HYFM $3.51
- PRPH $0.32
- Resistance Level
- HYFM $3.94
- PRPH $0.46
- Average True Range (ATR)
- HYFM 0.27
- PRPH 0.03
- MACD
- HYFM 0.01
- PRPH 0.01
- Stochastic Oscillator
- HYFM 94.24
- PRPH 75.57
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.